Premium
Pyoderma gangrenosum with spleen involvement and monoclonal IgA gammopathy
Author(s) -
Mijuşković Z̆P,
Zečević RD,
Pavlović MD
Publication year - 2004
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2004.01031.x
Subject(s) - medicine , pyoderma gangrenosum , prednisone , monoclonal gammopathy , pyoderma , spleen , hypergammaglobulinemia , dermatology , gastroenterology , monoclonal , surgery , monoclonal antibody , immunology , antibody , disease
A 46‐year‐old man with a 3‐year history of pyoderma gangrenosum was admitted with ulceration (6 × 5 cm), on the right leg. Previously he had been treated with tapering doses of prednisone (maximum dose 1 mg/kg per day); however, he had had a few exacerbations following each taper of prednisone dose. Immunoelectrophoresis demonstrated monoclonal IgA gammopathy of λ light chains. Abdominal echography and abdominal computed tomographic scan revealed multiple splenic abscesses. Treatment was started with oral prednisone (1 mg/kg per day) and cyclosporin (5 mg/kg per day) and 6 weeks later complete remission was achieved. Systemic involvement in pyoderma gangrenosum is very rare, and according to our knowledge there are only a few cases with spleen involvement.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom